These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 12084624)

  • 1. A cellular cofactor in HIV-1 assembly: INI1 is also an "outtie".
    Landau NR
    Trends Pharmacol Sci; 2002 Jun; 23(6):252-3. PubMed ID: 12084624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond Tsg101: the role of Alix in 'ESCRTing' HIV-1.
    Fujii K; Hurley JH; Freed EO
    Nat Rev Microbiol; 2007 Dec; 5(12):912-6. PubMed ID: 17982468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance is futile: assimilation of cellular machinery by HIV-1.
    Perez OD; Nolan GP
    Immunity; 2001 Nov; 15(5):687-90. PubMed ID: 11728331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function.
    Demirov DG; Ono A; Orenstein JM; Freed EO
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):955-60. PubMed ID: 11805336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defects in human immunodeficiency virus budding and endosomal sorting induced by TSG101 overexpression.
    Goila-Gaur R; Demirov DG; Orenstein JM; Ono A; Freed EO
    J Virol; 2003 Jun; 77(11):6507-19. PubMed ID: 12743307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The action of TSG101 on HIV-1 budding and related inhibitors].
    Chen HF; Liu XY
    Yao Xue Xue Bao; 2008 Dec; 43(12):1165-70. PubMed ID: 19244744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of early steps of HIV-1 replication by SNF5/Ini1.
    Maroun M; Delelis O; Coadou G; Bader T; Ségéral E; Mbemba G; Petit C; Sonigo P; Rain JC; Mouscadet JF; Benarous R; Emiliani S
    J Biol Chem; 2006 Aug; 281(32):22736-43. PubMed ID: 16772295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tsg101 control of human immunodeficiency virus type 1 Gag trafficking and release.
    Goff A; Ehrlich LS; Cohen SN; Carter CA
    J Virol; 2003 Sep; 77(17):9173-82. PubMed ID: 12915533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of viral and cellular proteins in the budding of human immunodeficiency virus.
    Mazzé FM; Degrève L
    Acta Virol; 2006; 50(2):75-85. PubMed ID: 16808324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding.
    Garrus JE; von Schwedler UK; Pornillos OW; Morham SG; Zavitz KH; Wang HE; Wettstein DA; Stray KM; Côté M; Rich RL; Myszka DG; Sundquist WI
    Cell; 2001 Oct; 107(1):55-65. PubMed ID: 11595185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between Nef and INI1/SMARCB1 augments replicability of HIV-1 in resting human peripheral blood mononuclear cells.
    Pyeon D; Park IW
    Arch Virol; 2015 Mar; 160(3):727-37. PubMed ID: 25559666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vpu and Tsg101 regulate intracellular targeting of the human immunodeficiency virus type 1 core protein precursor Pr55gag.
    Harila K; Prior I; Sjöberg M; Salminen A; Hinkula J; Suomalainen M
    J Virol; 2006 Apr; 80(8):3765-72. PubMed ID: 16571793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability in the P6gag domains of HIV-1 involved in viral budding.
    Holguín A; Alvarez A; Soriano V
    AIDS; 2006 Feb; 20(4):624-7. PubMed ID: 16470130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress.
    Martin-Serrano J; Zang T; Bieniasz PD
    Nat Med; 2001 Dec; 7(12):1313-9. PubMed ID: 11726971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Super-resolution imaging of ESCRT-proteins at HIV-1 assembly sites.
    Prescher J; Baumgärtel V; Ivanchenko S; Torrano AA; Bräuchle C; Müller B; Lamb DC
    PLoS Pathog; 2015 Feb; 11(2):e1004677. PubMed ID: 25710462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of vacuolar protein sorting pathway in Ebola virus release independent of TSG101 interaction.
    Silvestri LS; Ruthel G; Kallstrom G; Warfield KL; Swenson DL; Nelle T; Iversen PL; Bavari S; Aman MJ
    J Infect Dis; 2007 Nov; 196 Suppl 2():S264-70. PubMed ID: 17940959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TSG101: a novel anti-HIV-1 drug target.
    Chen H; Liu X; Li Z; Zhan P; De Clercq E
    Curr Med Chem; 2010; 17(8):750-8. PubMed ID: 20088757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The integrase interactor 1 (INI1) proteins facilitate Tat-mediated human immunodeficiency virus type 1 transcription.
    Ariumi Y; Serhan F; Turelli P; Telenti A; Trono D
    Retrovirology; 2006 Aug; 3():47. PubMed ID: 16889668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 nucleocapsid and ESCRT-component Tsg101 interplay prevents HIV from turning into a DNA-containing virus.
    Chamontin C; Rassam P; Ferrer M; Racine PJ; Neyret A; Lainé S; Milhiet PE; Mougel M
    Nucleic Acids Res; 2015 Jan; 43(1):336-47. PubMed ID: 25488808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 Vpr Abrogates the Effect of TSG101 Overexpression to Support Virus Release.
    Chutiwitoonchai N; Siarot L; Takeda E; Shioda T; Ueda M; Aida Y
    PLoS One; 2016; 11(9):e0163100. PubMed ID: 27648839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.